Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.
about
The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection.Plasmid cDNA-directed protein synthesis in a coupled eukaryotic in vitro transcription-translation system.Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited.A plasmid vehicle suitable for the molecular cloning and characterization of mammalian promotersIn vitro transcription and translational efficiency of chimeric SP6 messenger RNAs devoid of 5' vector nucleotidesRelationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activityA pollen-specific DEAD-box protein related to translation initiation factor eIF-4A from tobacco.Translation in Saccharomyces cerevisiae: initiation factor 4E-dependent cell-free systemCap-independent enhancement of translation by a plant potyvirus 5' nontranslated regionThe adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiationAn internal 5'-noncoding region required for translation of poliovirus RNA in vitroRestriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavagemRNAs containing the unstructured 5' leader sequence of alfalfa mosaic virus RNA 4 translate inefficiently in lysates from poliovirus-infected HeLa cells.Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.Unusual ribosome binding properties of mRNA encoding bacteriophage lambda repressor.Studies on the mechanism of translational enhancement by the 5'-leader sequence of tobacco mosaic virus RNA.
P2860
Q33962536-362F2995-5AF7-4134-9C2B-1C34F2B513C5Q34250894-C81FE7DD-230D-43D4-B2A2-A66FC2A531B5Q34294116-DA9BAF62-59D2-4F1D-9821-E4C7FB676128Q35444017-AE02BE39-D3F1-4DB5-A180-9C78C4F789BFQ36005483-022CA9AC-0BBB-48BE-9AC4-37EC6EBC3F12Q36697427-75629B5A-AFB2-45BC-A2A0-30226A00D66DQ36701516-8449CFE1-93E4-4123-B1B2-EABE10A98C26Q36762549-DF5FE7B3-5454-4E76-AEDE-56746D56DE01Q36803474-F4787AEA-76F9-49E9-B2FB-1E7C1DF77F13Q36869025-BCFE6BF2-3609-4609-8DE4-1EDC7F513EB7Q36879652-AF2A44D5-278B-40E7-AF4D-BE5399871E0DQ36916290-2032CA98-C70A-4F0E-9482-9208D6D908FCQ39871245-073CFDA2-BDAA-4058-9D1F-2374C35ED973Q40131932-7362CBEF-7C5F-456A-8048-8700E0598249Q40411828-0614E17C-B106-440F-9DB6-4F5E2A6C980DQ41968149-8F0B5657-6DBA-4174-8ED4-EECE6099D3FD
P2860
Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Capped mRNAs with reduced seco ...... rom poliovirus-infected cells.
@en
type
label
Capped mRNAs with reduced seco ...... rom poliovirus-infected cells.
@en
prefLabel
Capped mRNAs with reduced seco ...... rom poliovirus-infected cells.
@en
P2093
P2860
P356
P1476
Capped mRNAs with reduced seco ...... rom poliovirus-infected cells.
@en
P2093
P2860
P304
P356
10.1128/MCB.2.12.1633
P407
P577
1982-12-01T00:00:00Z